A better understanding of the determinants of public health care expenditures is key to designing effective health policies. We integrate supply and demand-side determinants, factors from political economy and health policy reforms into an empirical analysis of the highly decentralized Swiss...

This study examines the impact of the gubernatorial partisanship on the growth of health care expenditures for the panel data set of 50 U.S. states over the 1991 to 2009 period. Using the parametric regression discontinuity design, I find no partisan effect on the growth of state's per capita...

On March 18, Congress enacted the Families First Coronavirus Response Act, the first economic relief bill in response to the pandemic. It mandates that state Medicaid programs cover diagnosis and testing for COVID-19 at no cost to beneficiaries and includes a temporary, conditional 6.2...

Governments worldwide are increasingly concerned about the booming CBD (cannabidiol) products. However, little is known about the impact of their liberalization. We study a unique case of unintended liberalization of a CBD-based product (light cannabis) that occurred in Italy in 2017. Using...

Growth in healthcare spending by provinces and territories has been accelerating over the last four years as governments continue to overshoot their budget targets, says a report from the C.D. Howe Institute. In “Healthcare Spending Overshoots a Threat to Sustainability,” author William B.P....

The medical community often argues that physician fear of legal liability increases health care spending. Theoretically, though, the effect could be positive or negative, and empirical evidence has supported both cases. Previous empirical work, however, has ignored the fact that physicians face...

The paper provides an analysis of the determinants of health spending differentials among the Italian Regions for the years 1998-2010. An original standardised spending framework is proposed that takes into account the appropriateness of the services provided and price/technical efficiency, as...

The paper aims to analyse the extent to which the adoption of best practice policies could improve the efficiency of Italian Regional Healthcare Systems (RHSs) and reduce public healthcare expenditures. By means of a stochastic frontier model we estimate the RHSs’ technical inefficiency and...

The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...